Nemluvio
Nemolizumab-ilto · Galderma Laboratories, L.P.
PRESCRIPTION ONLY (USA)Nemluvio ingredients
| Active ingredient | Strength |
|---|---|
| Nemolizumab | 30 mg/100mg |
What Nemluvio is used for
Nemluvio is a specialist medicine (interleukin-31 receptor alpha antagonist). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Nemluvio
- Generic name
- Nemolizumab-ilto
- Made by
- Galderma Laboratories, L.P.
- Forms
- Injection, Powder, Lyophilized, For Solution
- Given
- Subcutaneous
- Drug class
- Interleukin-31 Receptor alpha Antagonist
- FDA approval
- Biologic licence (BLA) BLA761390
- On the US market since
- 2024
Official information
- Nemluvio prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Nemolizumab-ilto)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Nemluvio?
Nemluvio (Nemolizumab-ilto) is a specialist medicine made by Galderma Laboratories, L.P., approved by the US FDA.
What are the ingredients of Nemluvio?
Nemluvio contains Nemolizumab (30 mg/100mg).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA